Myriad Stymies Cancer Answers by Impeding Data Sharing
This article is for subscribers only.
Tory Galloway thought her negative result on a widely-used test sold by Myriad Genetics Inc. cleared her DNA as a cause for her fallopian tube cancer.
She happily advised her four sisters that the disease didn’t result from a family trait. The relief from the December 2010 test, though, was short lived. In October, after getting results from a broader scan at the University of Washington that included dozens of genes, she learned the truth: Her cancer was caused by a mutation that wasn’t included in the Myriad product.